Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Zuvich

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Protocols in Pharmacology|September 17, 2016
A Mouse Model of Furosemide-Induced Overactive BladderMichael S Saporito, Eva Zuvich, Amy DiCamillo
Psychopharmacology|June 16, 2010
The effects of d-amphetamine, methylphenidate, sydnocarb, and caffeine on prepulse inhibition of the startle reflex in DBA/2 miceDorothy G Flood, Eva Zuvich, Michael J Marino, et al.
Psychopharmacology|February 9, 2011
Prepulse inhibition of the startle reflex and response to antipsychotic treatments in two outbred mouse strains in comparison to the inbred DBA/2 mouseDorothy G Flood, Eva Zuvich, Michael J Marino, et al.
Biochemical Pharmacology|July 20, 2010
Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 miceKarla Kopec, Dorothy G Flood, Maciej Gasior, et al.
Journal of Medicinal Chemistry|February 24, 2007
Discovery of (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol- 6(2H)-one, a selective, orally active agonist of the 5-HT(2C) receptorDean A Wacker, Jeffrey G Varnes, Sarah E Malmstrom, et al.
Journal of Medicinal Chemistry|November 5, 2013
Reductions in log P improved protein binding and clearance predictions enabling the prospective design of cannabinoid receptor (CB1) antagonists with desired pharmacokinetic propertiesBruce A Ellsworth, Philip M Sher, Ximao Wu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Protocols in Pharmacology|September 17, 2016
A Mouse Model of Furosemide-Induced Overactive BladderMichael S Saporito, Eva Zuvich, Amy DiCamillo
Psychopharmacology|June 16, 2010
The effects of d-amphetamine, methylphenidate, sydnocarb, and caffeine on prepulse inhibition of the startle reflex in DBA/2 miceDorothy G Flood, Eva Zuvich, Michael J Marino, et al.
Psychopharmacology|February 9, 2011
Prepulse inhibition of the startle reflex and response to antipsychotic treatments in two outbred mouse strains in comparison to the inbred DBA/2 mouseDorothy G Flood, Eva Zuvich, Michael J Marino, et al.
Biochemical Pharmacology|July 20, 2010
Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 miceKarla Kopec, Dorothy G Flood, Maciej Gasior, et al.
Journal of Medicinal Chemistry|February 24, 2007
Discovery of (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol- 6(2H)-one, a selective, orally active agonist of the 5-HT(2C) receptorDean A Wacker, Jeffrey G Varnes, Sarah E Malmstrom, et al.
Journal of Medicinal Chemistry|November 5, 2013
Reductions in log P improved protein binding and clearance predictions enabling the prospective design of cannabinoid receptor (CB1) antagonists with desired pharmacokinetic propertiesBruce A Ellsworth, Philip M Sher, Ximao Wu, et al.
Pageof 1